Tyra Biosciences, Inc. (TYRA)
NASDAQ: TYRA · Real-Time Price · USD
10.54
+0.24 (2.33%)
May 1, 2025, 4:00 PM EDT - Market closed

Tyra Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Market Capitalization
560731596318572-
Upgrade
Market Cap Growth
22.61%22.61%87.61%-44.42%--
Upgrade
Enterprise Value
20937738757260-
Upgrade
Last Close Price
10.3013.9013.857.6014.07-
Upgrade
PB Ratio
1.522.132.921.231.90-
Upgrade
P/TBV Ratio
1.592.132.921.231.90-
Upgrade
Debt / Equity Ratio
0.020.020.030.010.000.01
Upgrade
Quick Ratio
23.5323.5313.3244.0783.578.19
Upgrade
Current Ratio
23.8123.8113.8145.1384.098.22
Upgrade
Return on Equity (ROE)
-31.60%-31.60%-29.92%-19.77%-16.66%-201.38%
Upgrade
Return on Assets (ROA)
-22.09%-22.09%-20.31%-12.86%-10.18%-70.27%
Upgrade
Return on Capital (ROIC)
-23.25%-23.25%-21.21%-13.08%-10.36%-120.22%
Upgrade
Earnings Yield
-15.89%-11.83%-11.59%-17.41%-4.60%-
Upgrade
FCF Yield
-12.94%-9.63%-8.54%-16.00%-4.27%-
Upgrade
Buyback Yield / Dilution
-33.98%-33.98%-1.96%-203.94%-793.58%41.81%
Upgrade
Updated Nov 7, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q